Abstract
Deposition of Lipiodol and absence of arterial enhancement after conventional TACE have been shown to correlate with coagulation necrosis in treated tumors, but these changes may not result in reduced tumor size. RECIST criteria are based solely on change in tumor size while the RECIST Amendment for Tumor Response Evaluation (2D EASL) criteria assess tumor necrosis. The purpose of this study was to compare RECIST criteria (version 1.1) and 2D EASL criteria in evaluating tumor response and patient survival after conventional TACE for HCC.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
